Skip to main content

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Agency: Food and Drug Administration

Assistance Listings
  • 93.103 -- Food and Drug Administration Research

Forecasted opportunityLast Updated: May 13, 2026

Important dates

  • Forecasted post date: Not specified
  • Forecasted application due date: Not specified
  • Forecasted award date: Not specified
  • Forecasted project start date: Not specified
  • Fiscal Year: 2025

Award details

  • Expected project funding: Not specified
  • Expected awards: Not specified

Award min.

$650,000

Award max.

$900,000

  • Funding opportunity number:FOR-FD-25-001
  • Cost sharing or matching requirement:No
  • Funding instrument type:
    • Grant
  • Opportunity Category:Discretionary
  • Opportunity Category Explanation:Not specified
  • Category of Funding Activity:
    • Consumer protection
    • Food and nutrition
    • Agriculture
  • Category Explanation:Not specified

History

  • Forecast posted date: August 14, 2024
  • Archive date: Not specified
  • Version: 1

View version history on Grants.gov

Summary

The purpose is to fund clinical trials of products evaluating efficacy and/or safety in support of a new indication or change in labeling to address unmet needs in rare neurodegenerative diseases for children and adults. Through the support of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare neurodegenerative diseases and exert a broad and positive impact on rare disease drug development.

Eligibility

Government

  • Special district governments
  • Public and Indian housing authorities
  • State governments
  • Federally recognized Native American tribal governments
  • City or township governments
  • County governments

Nonprofit

  • Nonprofits non-higher education with 501(c)(3)
  • Other Native American tribal organizations
  • Nonprofits non-higher education without 501(c)(3)

Education

  • Public and state institutions of higher education
  • Independent school districts
  • Private institutions of higher education

Miscellaneous

  • Unrestricted

Business

  • Small businesses
  • For-profit organizations other than small businesses

Additional information on eligibility

Not specified

Documents

No documents are currently available.

Agency contact information

Email: terrin.brown@fda.hhs.gov

terrin.brown@fda.hhs.gov

Terrin Brown Grantor 2404027610

Link to additional information

No additional information is available

HHS.gov

An official website of the U.S. Department of Health and Human Services

Looking for U.S. government information and services? Visit USA.gov